Skip to content

Epidemiology of Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03598543
Enrollment
100
Registered
2018-07-26
Start date
2018-06-01
Completion date
2018-12-31
Last updated
2018-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Klebsiella Pneumoniae Infection

Brief summary

Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Detailed description

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, outcome and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Interventions

OTHERno intervention

no intervention, this is an obervational study.

Sponsors

Sir Run Run Shaw Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

\- new confirmed community-onset or noscomial infection of Klebsiella pneumoniae infection

Exclusion criteria

* Age\<18, or \>85 years old; Mixed infection of Klebsiella pneumoniae and other microbes

Design outcomes

Primary

MeasureTime frameDescription
CRKP infection6 monthsCulture postitive results confirmed the infection of CRKP

Countries

China

Contacts

Primary ContactYing-zhi FANG, Master
fyz4817@126.com+86 57186006811
Backup ContactPing Zhang, MD
+86-571-8600-6142

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026